E-cig use increases risk of beginning tobacco cigarette use in young adults
PITTSBURGH, Dec. 11, 2017 - Young adults who use electronic cigarettes are more than four times as likely to begin smoking tobacco cigarettes within 18...
NEWS INDEX
Soy, cruciferous vegetables associated with fewer common breast cancer treatment side effects
WASHINGTON -- Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts,...
Low-dose treatment with Il2 across studies shows benefits in chronic graft-versus host
ATLANTA - Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host disease following stem cell transplants,...
Study shows combining chemotherapy with targeted drug boosts response in chronic lymphocytic leukemia
ATLANTA - Among younger patients newly diagnosed with chronic lymphocytic leukemia (CLL), treatment with a combination of chemotherapy and a molecularly targeted drug significantly improves...
CAR T, immunotherapy bring new hope for multiple myeloma patients
PHILADELPHIA - Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients...
Phase 2 CAR-T study reports significant remission rates at 15-month follow up
Credit: MD Anderson Cancer Center A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows that 42 percent of patients...
Global CAR T therapy trial shows high rates of durable remission for NHL
PHILADELPHIA - In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah⢠(formerly known as...
Landmark CAR-T cancer study published in the New England Journal of Medicine
Credit: Loyola Medicine MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking...
Sequencing offers clues to progression toward multiple myeloma
ATLANTA -- Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma (SMM), a precursor to full-blown...
Rapid responses, few adverse effects in targeted agent in Phase1 trial in rare blood disorder
ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare blood disorder, had rapid and...
Tracking how multiple myeloma evolves by sequencing DNA in the blood
ATLANTA - Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the...
Physical activity data, emojis on Apple Watch correlated with patient-reported outcomes
ATLANTA - In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful...
Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant
ATLANTA - Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem...
For leukemia patients, transfusion needs may delay hospice care
Toward the end of life, some leukemia patients depend on blood transfusions to ease their suffering. Unfortunately, the likelihood that transfusions won't be accessible through...
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Credit: Seattle Children's SEATTLE - Dec. 9, 2017 - Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th...
